The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Deleting disease
- Trump ban definite – FBon January 12, 2021 at 9:08 am
AT least 13 million Filipinos will receive coronavirus disease 2019 (Covid-19 ... Twitter went a step further on Friday by deleting Trump’s account, depriving him of his favorite megaphone. Trump also ...
- CRISPR, Editas, Intellia: Gene Editing Stocks To Play The Next Revolution In Medicineon January 11, 2021 at 7:00 am
Gene editing has emerged as a promising biotech theme. The technology is used to insert, edit, or delete a gene from an organism’s genome, helping to replace the defective genes responsible for a ...
- Baltimore woman helps educate African Americans about the increased threat of Alzheimer’s disease they faceon January 11, 2021 at 6:00 am
As family care coordinator with the Alzheimer’s Association Greater Maryland Chapter, Marlyn Taylor is helping to educate African Americans about the disease, which affects them at twice the amount as ...
- The Zacks Analyst Blog Highlights: Intellia Therapeutics, Editas Medicine, Fate Therapeutic, CRISPR Therapeutics and Vertex Pharmaceuticalson January 11, 2021 at 5:02 am
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks ...
- Researchers receive NIH grant to develop more effective flu vaccineson January 10, 2021 at 11:04 pm
To build better vaccines, scientists want to know more about how our bodies make adequate numbers of effective, durable antibodies against the influenza virus.
Go deeper with Google Headlines on:
Deleting disease
Go deeper with Bing News on:
Protein editorial assistants
- Replimune Announces First Patient Dosed with RP3 in a Phase 1 Clinical Trial in Patients with Advanced Solid Tumorson January 11, 2021 at 7:29 am
Replimune Group, Inc. (NASDAQ: REPL), a biotechnology company developing oncolytic immuno-gene therapies derived from its Immulytic™ platform, announced it has dosed the first patient in a Phase 1, ...
- Novavax Finalizes Agreement with Commonwealth of Australia for 51 Million Doses of COVID-19 Vaccineon January 10, 2021 at 9:48 am
CoV2373, Novavax’ adjuvanted protein vaccine candidate Initial doses expected to be delivered as early as mid-2021 GAITHERSBURG, Md., Jan. 07, 2021 — Novavax, Inc. (Nasdaq: NVAX), a late-stage ...
- DNA-editing Technique Shows Promise to Treat Progeria, Aging Disorderon January 7, 2021 at 3:06 pm
This change increases the production of the toxic protein progerin ... have therapeutic benefit," said Jonathan D. Brown, M.D., assistant professor of medicine in the Division of Cardiovascular ...
- Protein that can be toxic in the heart and nerves may help prevent Alzheimer'son January 7, 2021 at 12:12 pm
One of these, a protein known as transthyretin (TTR), seemed to play a protective role, explains Lorena Saelices, Ph.D., assistant professor of biophysics and in the Center for Alzheimer's and ...
- Relay Therapeutics Uses AWS to Accelerate Drug Discoveryon January 7, 2021 at 9:50 am
Relay Therapeutics is a precision medicine company transforming the drug discovery process by leveraging unparalleled insights into protein motion. Prior to testing promising compounds in the lab, ...